Bristol Myers Squibb Stock Analysis

Bristol Stock Analysis Notes

About 78.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.06. Bristol Myers Squibb recorded a loss per share of 3.58. The entity last dividend was issued on the 4th of October 2024. The firm had 1000000:95 split on the 7th of August 2001. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company was founded in 1887 and is headquartered in New York, New York. Bristol-Myers Squibb operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 32200 people. For more info on Bristol Myers Squibb please contact Giovanni Caforio at 609 252 4621 or go to https://www.bms.com.

Bristol Myers Squibb Investment Alerts

Bristol Myers Squibb Upcoming and Recent Events

Bristol Largest EPS Surprises

View All Earnings Estimates

Bristol Myers Environmental, Social, and Governance (ESG) Scores

Bristol Myers Thematic Classifications

Bristol Stock Institutional Investors

Note, although Bristol Myers' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bristol Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 119.4 B.

Bristol Profitablity

The company has Net Profit Margin of (0.15) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.

Management Efficiency

Bristol Myers Squibb has Return on Asset of 0.0607 % which means that on every $100 spent on assets, it made $0.0607 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3133) %, meaning that it generated no profit with money invested by stockholders. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bristol Myers' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.14 in 2024, whereas Return On Tangible Assets are likely to drop 0.15 in 2024. At this time, Bristol Myers' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 66.6 B in 2024, whereas Other Assets are likely to drop slightly above 3.3 B in 2024.

Technical Drivers

As of the 25th of November, Bristol Myers shows the Risk Adjusted Performance of 0.1454, downside deviation of 1.49, and Mean Deviation of 1.31. Bristol Myers Squibb technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bristol Myers Squibb Price Movement Analysis

Bristol Myers Squibb Insider Trading Activities

Bristol Myers Outstanding Bonds

Bristol Myers Predictive Daily Indicators

Bristol Myers Corporate Filings

Bristol Myers Forecast Models

Bristol Myers' time-series forecasting models are one of many Bristol Myers' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bristol Myers' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bristol Myers prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bristol shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bristol Myers. By using and applying Bristol Stock analysis, traders can create a robust methodology for identifying Bristol entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bristol analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bristol analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bristol Myers Squibb stock analysis indicators help investors evaluate how Bristol Myers stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bristol Myers shares will generate the highest return on investment. By understating and applying Bristol Myers stock analysis, traders can identify Bristol Myers position entry and exit signals to maximize returns.

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.